Tech Company Financing Transactions
Cellzome AG Funding Round
INVESCO Private Capital, Advent International and Atlas Venture participated in a $38.3 million Series C funding round for Cellzome AG. The round closed on 3/18/2003.
Transaction Overview
Company Name
Announced On
3/18/2003
Transaction Type
Venture Equity
Amount
$38,330,400
Round
Series C
Investors
INVESCO Private Capital (Lead Investor) (Parag Saxena)
Proceeds Purpose
The funds raised in this round will be used to fund R&D and proof-of-concept studies. SG Cowen was the placement agent.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Meyerhofstrasse 1
Heidelberg, 69117
Germany
Heidelberg, 69117
Germany
Phone
Website
Email Address
Overview
Cellzome is a privately-owned drug discovery company applying its world-class technology towards the discovery of novel small molecule therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Edwards
Chief Scientific Officer
David Simmons
VP - Bus. Development
Jane Dancer
VP - Finance
Markus Reinhard
VP - Operations
Gitte Neubauer
Browse more venture capital transactions:
Prev: 3/18/2003: Silicon Optix venture capital transaction
Next: 3/19/2003: Targacept venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs